|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Chain Administration Prevents Murine Collagen-Induced Arthritis: A Role for IL-15 in Development of Antigen-Induced Immunopathology1
* Department of Immunology and Centre for Rheumatic Diseases, University of Glasgow, United Kingdom
IL-15 has recently been detected in the synovium of patients with
rheumatoid arthritis. IL-15-activated T cells induce significant
TNF-
synthesis by macrophages via a cell contact-dependent
mechanism, suggesting a key regulatory role for IL-15. Here, we report
that the administration of a soluble fragment of IL-15R
into DBA/1
mice, profoundly suppressed the development of collagen-induced
arthritis. This was accompanied in vitro by marked reductions in
Ag-specific proliferation and IFN-
synthesis by spleen cells from
treated mice compared with control mice and in vivo by a significant
reduction in serum anti-collagen Ab levels. These data directly
demonstrate a pivotal role for IL-15 in the development of inflammatory
arthritis and also suggest that antagonists to IL-15 may have
therapeutic potential in rheumatic diseases.
This article has been cited by other articles:
![]() |
T. Kawasaki, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Effect of interleukin-15 on depressed splenic dendritic cell functions following trauma-hemorrhage Am J Physiol Cell Physiol, January 1, 2009; 296(1): C124 - C130. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Verri Jr., A. T. G. Guerrero, S. Y. Fukada, D. A. Valerio, T. M. Cunha, D. Xu, S. H. Ferreira, F. Y. Liew, and F. Q. Cunha IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice PNAS, February 19, 2008; 105(7): 2723 - 2728. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bergamaschi, M. Rosati, R. Jalah, A. Valentin, V. Kulkarni, C. Alicea, G.-M. Zhang, V. Patel, B. K. Felber, and G. N. Pavlakis Intracellular Interaction of Interleukin-15 with Its Receptor {alpha} during Production Leads to Mutual Stabilization and Increased Bioactivity J. Biol. Chem., February 15, 2008; 283(7): 4189 - 4199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Olsen, N. Ota, S. Kishishita, M. Kukimoto-Niino, K. Murayama, H. Uchiyama, M. Toyama, T. Terada, M. Shirouzu, O. Kanagawa, et al. Crystal Structure of the Interleukin-15{middle dot}Interleukin-15 Receptor {alpha} Complex: INSIGHTS INTO TRANS AND CIS PRESENTATION J. Biol. Chem., December 21, 2007; 282(51): 37191 - 37204. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanaba, Y. Hamaguchi, G. M. Venturi, D. A. Steeber, E. W. St. Clair, and T. F. Tedder B Cell Depletion Delays Collagen-Induced Arthritis in Mice: Arthritis Induction Requires Synergy between Humoral and Cell-Mediated Immunity J. Immunol., July 15, 2007; 179(2): 1369 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bulanova, V. Budagian, E. Duitman, Z. Orinska, H. Krause, R. Ruckert, N. Reiling, and S. Bulfone-Paus Soluble Interleukin (IL)-15R{alpha} Is Generated by Alternative Splicing or Proteolytic Cleavage and Forms Functional Complexes with IL-15 J. Biol. Chem., May 4, 2007; 282(18): 13167 - 13179. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Stoklasek, K. S. Schluns, and L. Lefrancois Combined IL-15/IL-15R{alpha} Immunotherapy Maximizes IL-15 Activity In Vivo J. Immunol., November 1, 2006; 177(9): 6072 - 6080. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohteki, H. Tada, K. Ishida, T. Sato, C. Maki, T. Yamada, J. Hamuro, and S. Koyasu Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo J. Exp. Med., October 2, 2006; 203(10): 2329 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Verri Jr., T. M. Cunha, C. A. Parada, X.-q. Wei, S. H. Ferreira, F. Y. Liew, and F. Q. Cunha IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-{gamma}, endothelin, and prostaglandin PNAS, June 20, 2006; 103(25): 9721 - 9725. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Rubinstein, M. Kovar, J. F. Purton, J.-H. Cho, O. Boyman, C. D. Surh, and J. Sprent Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha} PNAS, June 13, 2006; 103(24): 9166 - 9171. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Combe, M. M. Moretto, J. D. Schwartzman, J. P. Gigley, D. J. Bzik, and I. A. Khan Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite PNAS, April 25, 2006; 103(17): 6635 - 6640. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lorenzen, A. J. Dingley, Y. Jacques, and J. Grotzinger The Structure of the Interleukin-15{alpha} Receptor and Its Implications for Ligand Binding J. Biol. Chem., March 10, 2006; 281(10): 6642 - 6647. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Amlong, D. T. Nardelli, S. H. Peterson, T. F. Warner, S. M. Callister, and R. F. Schell Anti-Interleukin-15 Prevents Arthritis in Borrelia-Vaccinated and -Infected Mice Clin. Vaccine Immunol., February 1, 2006; 13(2): 289 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mortier, A. Quemener, P. Vusio, I. Lorenzen, Y. Boublik, J. Grotzinger, A. Plet, and Y. Jacques Soluble Interleukin-15 Receptor {alpha} (IL-15R{alpha})-sushi as a Selective and Potent Agonist of IL-15 Action through IL-15Rbeta/{gamma}: HYPERAGONIST IL-15{middle dot}IL-15R{alpha} FUSION PROTEINS J. Biol. Chem., January 20, 2006; 281(3): 1612 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Morris, J. E. Janik, J. D. White, T. A. Fleisher, M. Brown, M. Tsudo, C. K. Goldman, B. Bryant, M. Petrus, L. Top, et al. Preclinical and phase I clinical trial of blockade of IL-15 using Mik{beta}1 monoclonal antibody in T cell large granular lymphocyte leukemia PNAS, January 10, 2006; 103(2): 401 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kutzler, T. M. Robinson, M. A. Chattergoon, D. K. Choo, A. Y. Choo, P. Y. Choe, M. P. Ramanathan, R. Parkinson, S. Kudchodkar, Y. Tamura, et al. Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help J. Immunol., July 1, 2005; 175(1): 112 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ruckert, K. Brandt, A. Braun, H.-G. Hoymann, U. Herz, V. Budagian, H. Durkop, H. Renz, and S. Bulfone-Paus Blocking IL-15 Prevents the Induction of Allergen-Specific T Cells and Allergic Inflammation In Vivo J. Immunol., May 1, 2005; 174(9): 5507 - 5515. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Sheu, S.-H. Chiou, H.-H. Lin, S.-N. Chow, S.-C. Huang, H.-N. Ho, and S.-M. Hsu Up-regulation of Inhibitory Natural Killer Receptors CD94/NKG2A with Suppressed Intracellular Perforin Expression of Tumor-Infiltrating CD8+ T Lymphocytes in Human Cervical Carcinoma Cancer Res., April 1, 2005; 65(7): 2921 - 2929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ferrari-Lacraz, E. Zanelli, M. Neuberg, E. Donskoy, Y. S. Kim, X. X. Zheng, W. W. Hancock, W. Maslinski, X. C. Li, T. B. Strom, et al. Targeting IL-15 Receptor-Bearing Cells with an Antagonist Mutant IL-15/Fc Protein Prevents Disease Development and Progression in Murine Collagen-Induced Arthritis J. Immunol., November 1, 2004; 173(9): 5818 - 5826. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Budagian, E. Bulanova, Z. Orinska, T. Pohl, E. C. Borden, R. Silverman, and S. Bulfone-Paus Reverse Signaling through Membrane-bound Interleukin-15 J. Biol. Chem., October 1, 2004; 279(40): 42192 - 42201. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Budagian, E. Bulanova, Z. Orinska, A. Ludwig, S. Rose-John, P. Saftig, E. C. Borden, and S. Bulfone-Paus Natural Soluble Interleukin-15R{alpha} Is Generated by Cleavage That Involves the Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE/ADAM17) J. Biol. Chem., September 24, 2004; 279(39): 40368 - 40375. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mortier, J. Bernard, A. Plet, and Y. Jacques Natural, Proteolytic Release of a Soluble Form of Human IL-15 Receptor {alpha}-Chain That Behaves as a Specific, High Affinity IL-15 Antagonist J. Immunol., August 1, 2004; 173(3): 1681 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Miranda-Carus, A. Balsa, M. Benito-Miguel, C. Perez de Ayala, and E. Martin-Mola IL-15 and the Initiation of Cell Contact-Dependent Synovial Fibroblast-T Lymphocyte Cross-Talk in Rheumatoid Arthritis: Effect of Methotrexate J. Immunol., July 15, 2004; 173(2): 1463 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Y Liew, X-Q Wei, and I B McInnes Role of interleukin 18 in rheumatoid arthritis Ann Rheum Dis, November 1, 2003; 62(90002): ii48 - 50. [Full Text] [PDF] |
||||
![]() |
I B McInnes, J A Gracie, M Harnett, W Harnett, and F Y Liew New strategies to control inflammatory synovitis: interleukin 15 and beyond Ann Rheum Dis, November 1, 2003; 62(90002): ii51 - 54. [Full Text] [PDF] |
||||
![]() |
F Y Liew and I B McInnes Role of interleukin 15 and interleukin 18 in inflammatory response Ann Rheum Dis, November 1, 2002; 61(90002): ii100 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Nguyen, T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X.-q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron Coordinated and Distinct Roles for IFN-{alpha}{beta}, IL-12, and IL-15 Regulation of NK Cell Responses to Viral Infection J. Immunol., October 15, 2002; 169(8): 4279 - 4287. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurowska, W. Rudnicka, E. Kontny, I. Janicka, M. Chorazy, J. Kowalczewski, M. Ziolkowska, S. Ferrari-Lacraz, T. B. Strom, and W. Maslinski Fibroblast-Like Synoviocytes from Rheumatoid Arthritis Patients Express Functional IL-15 Receptor Complex: Endogenous IL-15 in Autocrine Fashion Enhances Cell Proliferation and Expression of Bcl-xL and Bcl-2 J. Immunol., August 15, 2002; 169(4): 1760 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gri, C. Chiodoni, E. Gallo, A. Stoppacciaro, F. Y. Liew, and M. P. Colombo Antitumor Effect of Interleukin (IL)-12 in the Absence of Endogenous IFN-{gamma}: A Role for Intrinsic Tumor Immunogenicity and IL-15 Cancer Res., August 1, 2002; 62(15): 4390 - 4397. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ohta, T. Hiroi, M.-N. Kweon, N. Kinoshita, M. H. Jang, T. Mashimo, J.-I. Miyazaki, and H. Kiyono IL-15-Dependent Activation-Induced Cell Death-Resistant Th1 Type CD8{alpha}{beta}+NK1.1+ T Cells for the Development of Small Intestinal Inflammation J. Immunol., July 1, 2002; 169(1): 460 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan, M. Moretto, X.-q. Wei, M. Williams, J. D. Schwartzman, and F. Y. Liew Treatment with Soluble Interleukin-15R{alpha} Exacerbates Intracellular Parasitic Infection by Blocking the Development of Memory CD8+ T Cell Response J. Exp. Med., June 3, 2002; 195(11): 1463 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mattei, G. Schiavoni, F. Belardelli, and D. F. Tough IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation J. Immunol., August 1, 2001; 167(3): 1179 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lubberts, L. A. B. Joosten, B. Oppers, L. van den Bersselaar, C. J. J. Coenen-de Roo, J. K. Kolls, P. Schwarzenberger, F. A. J. van de Loo, and W. B. van den Berg IL-1-Independent Role of IL-17 in Synovial Inflammation and Joint Destruction During Collagen-Induced Arthritis J. Immunol., July 15, 2001; 167(2): 1004 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stemme Plaque T-Cell Activity : Not So Specific? Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1099 - 1101. [Full Text] [PDF] |
||||
![]() |
M. A. Houtkamp, A. C. van der Wal, O. J. de Boer, C. M. van der Loos, P. A. J. de Boer, A. F. M. Moorman, and A. E. Becker Interleukin-15 Expression in Atherosclerotic Plaques : An Alternative Pathway for T-Cell Activation in Atherosclerosis? Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1208 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-q. Wei, M. Orchardson, J. A. Gracie, B. P. Leung, B.-m. Gao, H. Guan, W. Niedbala, G. K. Paterson, I. B. McInnes, and F. Y. Liew The Sushi Domain of Soluble IL-15 Receptor {{alpha}} Is Essential for Binding IL-15 and Inhibiting Inflammatory and Allogenic Responses In Vitro and In Vivo J. Immunol., July 1, 2001; 167(1): 277 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Fehniger, K. Suzuki, A. Ponnappan, J. B. VanDeusen, M. A. Cooper, S. M. Florea, A. G. Freud, M. L. Robinson, J. Durbin, and M. A. Caligiuri Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype Cd8+ T Cells J. Exp. Med., January 15, 2001; 193(2): 219 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-q. Wei, B. P. Leung, H. M. L. Arthur, I. B. McInnes, and F. Y. Liew Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18 J. Immunol., January 1, 2001; 166(1): 517 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Fehniger and M. A. Caligiuri Interleukin 15: biology and relevance to human disease Blood, January 1, 2001; 97(1): 14 - 32. [Full Text] [PDF] |
||||
![]() |
X. G. Smith, E. M. Bolton, H. Ruchatz, X.-q. Wei, F. Y. Liew, and J. A. Bradley Selective Blockade of IL-15 by Soluble IL-15 Receptor {alpha}-Chain Enhances Cardiac Allograft Survival J. Immunol., September 15, 2000; 165(6): 3444 - 3450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Masuko-Hongo, M. Kurokawa, T. Kobata, K. Nishioka, and T. Kato Effect of IL15 on T cell clonality in vitro and in the synovial fluid of patients with rheumatoid arthritis Ann Rheum Dis, September 1, 2000; 59(9): 688 - 694. [Abstract] [Full Text] |
||||
![]() |
B. P. Leung, I. B. McInnes, E. Esfandiari, X.-Q. Wei, and F. Y. Liew Combined Effects of IL-12 and IL-18 on the Induction of Collagen-Induced Arthritis J. Immunol., June 15, 2000; 164(12): 6495 - 6502. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liu, K. Geboes, S. Colpaert, G. R. D'Haens, P. Rutgeerts, and J. L. Ceuppens IL-15 Is Highly Expressed in Inflammatory Bowel Disease and Regulates Local T Cell-Dependent Cytokine Production J. Immunol., April 1, 2000; 164(7): 3608 - 3615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ziolkowska, A. Koc, G. Luszczykiewicz, K. Ksiezopolska-Pietrzak, E. Klimczak, H. Chwalinska-Sadowska, and W. Maslinski High Levels of IL-17 in Rheumatoid Arthritis Patients: IL-15 Triggers In Vitro IL-17 Production Via Cyclosporin A-Sensitive Mechanism J. Immunol., March 1, 2000; 164(5): 2832 - 2838. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Fehniger, H. Yu, M. A. Cooper, K. Suzuki, M. H. Shah, and M. A. Caligiuri Cutting Edge: IL-15 Costimulates the Generalized Shwartzman Reaction and Innate Immune IFN-{gamma} Production In Vivo J. Immunol., February 15, 2000; 164(4): 1643 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamada, T. Nakamura, G. Matsuzaki, Y. Iwamoto, and K. Nomoto TCR-Independent Activation of Extrathymically Developed, Self Antigen-Specific T Cells by IL-2/IL-15 J. Immunol., February 15, 2000; 164(4): 1746 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kasyapa, C. L. Stentz, M. P. Davey, and D. W. Carr Regulation of IL-15-Stimulated TNF-{alpha} Production by Rolipram J. Immunol., September 1, 1999; 163(5): 2836 - 2843. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Estess, A. Nandi, M. Mohamadzadeh, and M. H. Siegelman Interleukin 15 Induces Endothelial Hyaluronan Expression in Vitro and Promotes Activated T Cell Extravasation through a Cd44-Dependent Pathway in Vivo J. Exp. Med., July 1, 1999; 190(1): 9 - 20. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |